7 | ProdrugsIBA
12/2018
-
07/2007 |
6 | Pharmaceutical PreparationsIBA
03/2022
-
11/2013 |
5 | CytokinesIBA
05/2021
-
05/2010 |
5 | Fluorouracil (Carac)FDA LinkGeneric
12/2018
-
01/2010 |
5 | Flucytosine (Ancobon)FDA Link
07/2013
-
07/2007 |
4 | Cisplatin (Platino)FDA LinkGeneric
04/2021
-
01/2016 |
4 | EnzymesIBA
11/2017
-
01/2010 |
4 | Cytosine DeaminaseIBA
07/2013
-
10/2008 |
3 | Adenosine Triphosphate (ATP)IBA
05/2021
-
11/2013 |
3 | Conditioned Culture MediaIBA
04/2015
-
11/2013 |
3 | uracil phosphoribosyltransferaseIBA
07/2013
-
10/2008 |
2 | Trastuzumab (Herceptin)FDA Link
03/2022
-
01/2020 |
2 | Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA
01/2020
-
01/2019 |
2 | Sodium-Calcium ExchangerIBA
01/2020
-
01/2019 |
2 | Small Interfering RNA (siRNA)IBA
01/2019
-
08/2018 |
2 | Ganciclovir (Cytovene)FDA LinkGeneric
04/2015
-
04/2010 |
1 | SeleniumIBA
05/2022 |
1 | 9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
05/2022 |
1 | triphenyltin (triphenyltin hydride)IBA
05/2022 |
1 | Antineoplastic Agents (Antineoplastics)IBA
05/2022 |
1 | Hormones (Hormone)IBA
05/2022 |
1 | isoselenocyanateIBA
05/2022 |
1 | DecitabineFDA Link
03/2022 |
1 | Doxorubicin (Adriamycin)FDA LinkGeneric
03/2022 |
1 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2021 |
1 | Type I Tumor Necrosis Factor ReceptorsIBA
05/2021 |
1 | LigandsIBA
05/2021 |
1 | Interleukin-6 (Interleukin 6)IBA
05/2021 |
1 | LGK974IBA
04/2021 |
1 | ICG 001IBA
04/2021 |
1 | CateninsIBA
04/2021 |
1 | Nifedipine (Adalat)FDA LinkGeneric
01/2020 |
1 | Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2020 |
1 | CalciumIBA
01/2020 |
1 | 1,4-dihydropyridine (dihydropyridine)IBA
01/2020 |
1 | Sodium-Hydrogen Exchanger 1IBA
01/2019 |
1 | GYY 4137IBA
01/2019 |
1 | Messenger RNA (mRNA)IBA
01/2019 |
1 | Proteins (Proteins, Gene)FDA Link
01/2019 |
1 | TransferasesIBA
12/2018 |
1 | Thymidine PhosphorylaseIBA
12/2018 |
1 | Thymidylate SynthaseIBA
12/2018 |
1 | Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
12/2018 |
1 | Lactic Acid (Lactate)FDA LinkGeneric
12/2016 |
1 | Tyrosine Kinase InhibitorsIBA
12/2016 |
1 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2016 |
1 | ((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA
12/2016 |
1 | GangliosidesIBA
04/2015 |
1 | AC133 AntigenIBA
03/2014 |
1 | Glycoproteins (Glycoprotein)IBA
03/2014 |
1 | ChemokinesIBA
11/2013 |
1 | Calcitonin (Calcitonin, Eel)FDA LinkGeneric
07/2013 |
1 | Biomarkers (Surrogate Marker)IBA
07/2013 |
1 | Neoplasm Antigens (Tumor Antigens)IBA
01/2013 |
1 | VaccinesIBA
01/2013 |
1 | Therapeutic UsesIBA
01/2013 |
1 | Protein SIBA
03/2012 |
1 | Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2010 |
1 | Chemokine CXCL12IBA
05/2010 |
1 | Thymidine KinaseIBA
04/2010 |
1 | Cytotoxins (Cytolysins)IBA
10/2008 |